• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/45

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

45 Cards in this Set

  • Front
  • Back

How does oncogenic Ras stimulate cell proliferation?

Oncogenic Ras short-cuts the need for an extracellular mitogenic signal to stimulate cell proliferation

Oncogenic Ras short-cuts the need for an extracellular mitogenic signal to stimulate cell proliferation

Oncogenic stress drives cell proliferation.




But oncogenic stress also results in the activation of what?

CKIs

CKIs

Sustained E2F activation results in the up regulation of what? How?

Oncogene-dependent activation of p16 and p21 results in what?

What happens is Rb is lost?

Sustained p53 activation promotes apoptosis

Sustained p53 activation promotes apoptosis

Describe the inhibition of Rb and p53 tumour suppressors by DNA tumour viruses

The HPV E7 protein, which is expressed early in the viral life-cycle, binds the 'pocket' of Rb, displacing it from E2F. E2F is therefore freed from Rb-dependent inhibition.


This activates the host cell's replicative machinery which the virus hij...

The HPV E7 protein, which is expressed early in the viral life-cycle, binds the 'pocket' of Rb, displacing it from E2F. E2F is therefore freed from Rb-dependent inhibition.




This activates the host cell's replicative machinery which the virus hijacks for its own propagation.




Additionally, the HPV E6 protein binds and inhibits p53, preventing apoptosis. This results in uncontrolled cell proliferation and survival.




The E7 and E6 viral proteins also promote the ubiquitination and degradation of Rb and p53.

In the absence of Rb (targetted E7 expression), how is lens development affected?

Lens fibre cells fail to withdraw from the cell cycle and fail to differentiate




Disorganised proliferation is counterbalanced by a high rate of apoptosis, consequently no tumours arise




Consequently no tumours arise

How is lens development affected in the absence of both Rb and p53? (targeted expression of both E7 and E6).

Lens fibre cells fail to withdraw from the cell cycle and fail to differentiate




However, apoptosis does not occur and lens cell division is unchecked.




Consequently, lens tumours develop.




This shows that the apoptosis response to Rb loss is p53-dependent.

Is loss of RB1 the only genetic change needed for Retinoblastoma?

It is now known that inactivation of the p53 tumour suppressor pathway also occurs in retinoblastoma




This would be predicted from experiments that show that Rb loss alone results in p53-dependent apoptosis




Tumourrigenesis is a multi-step process involving many genetic changes

p53 is a 53kDa _____________ _________ encoded by the ______ gene

transcription factor

p53 monomers associate to form a _________ _______________, which is recruited to p53-specific response elements in the ___________ of target genes

174 kDa tetramer


promoter

174 kDa tetramer




promoter

More than ____% of human tumours contain a mutation or deletion of the p53 gene

50

Chromosome __ long arm deletions are often accompanied by ___________ in the remaining TP53 allele

17


mutations

17




mutations

Many tumours lack p53 expression all together.




WT p53 actively ____________ oncogene-mediated cellular transformation

suppresses

p53 is a key node in signalling networks involved in sensing cellular stress




What activates p53?




What are some of the responses p53 can generate?

The response that p53 generates is dependent on the stress it encounter. Give an example.

If a cell is exposed to metabolic stress (e.g if energy/resources are scarce), you don't want the cell to go through the cell cycle because it probably doesn't have enough energy to replicate its genome. It makes more sense to transiently stop proliferation and wait for nutrients to become plentiful again, because going through the cell cycle. Under these cases, you might expect p53 to induce transient cell cycle arrest. It would be ridiculous for p53 to induce apoptosis whenever resources were depleted. In contrast, if the cell suffers massive DNA damage, i is a threat to the organism, so p53 induces apoptosis.

The biological functions of p53 are mostly due to the activities of p53-regulated gene products.




What are some of these gene products?

Describe the p53 life cycle in healthy cells, including the role of MDM2

In normal cells, the p53 gene should always be active, so p53 monomers are produced, which form a tetramer. The tetramer binds to the MDM2 promoter, and activate transcription of the MDM2 gene. MDM2 mRNA is exported to the cytoplasm, where it is t...

In normal cells, the p53 gene should always be active, so p53 monomers are produced, which form a tetramer. The tetramer binds to the MDM2 promoter, and activate transcription of the MDM2 gene. MDM2 mRNA is exported to the cytoplasm, where it is translated to MDM2 protein. Act is present in healthy cells, and phosphorylates MDM2 in the cytoplasm, promoting the nuclear import of MDM2.


MDM2 is a ubiquitin ligase. MDM2 binds to and ubiquinates p53, and so p53 is targeted for degradation.

p53 is activated by disrupting the ability of MDM2 to bind to p53. Why is this a better method of activating p53 vs increased transcription?

Because it takes time for a stress event to induce the transcription and then translation of MDM2.




This mechanism mans a rapid response is induced in response to stress.

In normal cells, what are p53 levels like and why?

Low




Due to the short half life of the protein (6-20 mins)

How does the p53 negative feedback response affect the levels of MDM2 and p53?

In normal cells p53 levels are low due to the short half-life of the protein (6- 20 min). This is because p53 is targeted by the E3-ubiquitin ligase MDM2.




Ubiquitination of p53 by MDM2 results in its nuclear _______ and ____________-mediated degradation.




However, MDM2 is a major _______________ target of p53 and as p53 levelsdiminish so, therefore, do those of MDM2.

export




proteasome




transcriptional

Arf only gets upregulated when there is excessive signalling from _____
Arf only gets upregulated when there is excessive signalling from _____

E2F

Oncogene activation results in increased transcription of Arf. How does this up regulate p53?

When Arf levels accumulate in response to oncogenic stress, Arf binds to MDM2, which relocalises it to the nucleolus (i.e it is physically speared from p53 so can't bind to it). This results in rapid accumulation of p53.

When Arf levels accumulate in response to oncogenic stress, Arf binds to MDM2, which relocalises it to the nucleolus (i.e it is physically speared from p53 so can't bind to it). This results in rapid accumulation of p53.

What does the CDKN2A gene encode?

Both the p16 and Arf tumour suppressors





The CDKN2A gene encodes both the p16 and Arf tumour suppressors.




How come?

p16INK4a and Arf transcription are initiated from different promoters and their respective mRNAsuse different exon combinations 


Arf protein is encoded by an alternate reading frame (Arf) to that of p16INK4a 


Consequently, although closely rel...

p16INK4a and Arf transcription are initiated from different promoters and their respective mRNAsuse different exon combinations




Arf protein is encoded by an alternate reading frame (Arf) to that of p16INK4a




Consequently, although closely related at the genetic level, these two tumour suppressors have completely unrelated amino acid sequences and protein structures




However, they play related and extremely important roles in the Rb pathway

Germline mutations in the CDKN2A gene are observed in 20–40% cases of _______ ____________

Germline mutations in the CDKN2A gene are observed in 20–40% cases of _______ ____________

familial melanoma




Rare cases in which CDK4 mutations have been associated with melanoma reveal a functional change that disrupts p16INK4a binding

Germline mutations in the CDKN2A gene are observed in 20-40% of cases of familial melanoma.

Rare cases in which CDK4 mutations have been associated with melanoma, reveal a functional change which disrupts what?
Germline mutations in the CDKN2A gene are observed in 20-40% of cases of familial melanoma.



Rare cases in which CDK4 mutations have been associated with melanoma, reveal a functional change which disrupts what?

p16 bind

Oncogenes such as myc and Ras promote the hyperactivation ofmitogenic signalling pathways (e.g. by up regulating ________expression)resulting in the __________________ and inhibition of Rb.




This in turndrives _______________ gene transcription.

cyclin D




hyperphosphorylation




E2F-mediated

Deregulated E2F activity promotes the transcriptional activation of the _____ protein.




Once expressed, _____ is recruited to the nucleus where it binds andsequesters MDM2 to the ____________, preventing its interaction with p53

Arf (x2)




nucleolus

DNA damage results in phosphorylation dependent ______________ of p53 and _______________ of MDM2

stabilisation




inhibition

DNA damage results in phosphorylation dependent stabilisation of p53 and inhibition of MDM2.




How?

DNA damage is detected by ‘sensor’ proteins which recognise eithersingle-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) breaks.


These sensors then recruit protein kinases that function as transducers ofthe DNA damage signal, phosphoryla...

DNA damage is detected by ‘sensor’ proteins which recognise eithersingle-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) breaks.




These sensors then recruit protein kinases that function as transducers ofthe DNA damage signal, phosphorylating downstream effector proteinsincluding p53 and MDM2.




dsDNA breaks are recognised by the MRN sensorcomplex which recruits the protein kinase ATM.




ATM then phosphorylates p53 either directly or indirectly via theactivation of the checkpoint kinases (Chk1 and Chk2).




DNA-PK (DNA-dependent protein kinase) is also recruited to dsDNA breaks.




ssDNA breaks are recognised by the sensor protein RPA (replication proteinA) which then recruits the protein kinase ATR .




ATR phosphorylates the Chk1/2 kinases, thereby promotingthe downstream phosphorylation of p53.




ATR, ATM and DNA-PK phosphorylate Ser15 of p53, while Chk1/2phosphorylate Ser20.




These residues lie within the N-terminal transactivationdomain of p53 and regulate MDM2 binding. Ser15/Ser20 phosphorylation ofp53 inhibits MDM2 binding, resulting in p53 stabilization and accumulation.




In addition to targeting p53, the Chk1/2 kinases also phosphorylate MDM2(at a residue district from that targeted by Akt), reducing its affinity for p53.





Rising p53 levels induce cell cycle arrest through the transcriptional activation of ____, a CKI that targets and inhibits the _______________ complex, the activity of which is requires for G1/S transition.

p21




Cyclin E/Cdk2

What does Akt phosphorylation of MDM2 promote?




What does Chk1/2 phosphorylation of MDM2 promote?

Nuclear entry and p53 association




p53 dissociation

What happened one the DNA damage has been repaired?

The DNA damage signals dissipate, p53 (and therefore p21 levels) declines, removing the barrier to cell cycle progression





What happens if DNA damage is so extensive that it is beyond repair?In

p53 can induce apoptosis, preventing the transmission of potentially dangerous genetic error to progeny cells

More than 50% of human tumours contain a mutation or deletion of the TP53 gene.




The majority of these mutations are what kind of mutation?

Missense mutations that impair p53-DNA binding

In tumours that retain a normal copy of the p53 gene, other elements of the p53 pathway are often defective.




Give some examples (3).

1. MDM2 or MDM4 over expression (e.g retinoblastoma-MDM2/4 levels exceed the sequestering capacity of Arf)




2. Inactivation of DNA-damage kinases (e.g germline mutations in Chk2 have been found in some Li Fraumeni-like families rather than p53 mutations)




3. Defective transcriptional regulation of p53 (e.g some breast tumours have low levels of p53 due to suppression of HOXA5, a transcription factor involved in p53 expression)

While some tumours exhibit complete loss of p53 expression or carry p53 mutations that result in loss of protein function, others express p53 mutants that antagonise the function of the wild-type protein.




What kind of mutations in p53 are these?





Dominant-negative p53 mutations




Gain-of-function p53 mutations

How do dominant negative p53 mutations disrupt normal p53 function?

These mutants interfere with the function of normal p53 by forming inactive tetramers 

Therefore, a similar result is obtained from mutating one allele as from deleting both

These mutants interfere with the function of normal p53 by forming inactive tetramers




Therefore, a similar result is obtained from mutating one allele as from deleting both

Other p53 mutations have been found to have a gain-of-function phenotype.




What observations resulted in the identification of p53 mutants which exhibit pro-oncogenic functions not usually associated with the wild-type protein?

Breast and colon cancer patients whose tumours carry certain missense p53 mutations tend to have a poorer prognosis than patients with p53 null tumours




Expression of certain p53 mutants in ells lacking normal p53 enhances the cell's tumorigenic potential

What are 3 kinds of gain of function mutations in p53?

Altered target gene specificity (the inappropriate transcriptional activation of genes associated with cell growth/survival ,e.g E2F, NFkB. These mutations likely alter the spectrum of gene promoters recognised by p53)




A switch from transcriptional repression to activation (the transcriptional activation of genes usually suppressed by p53 function, e.g c-myc)




Production of chemoresistance (up regulation of genes associated with cancer chemoresistance-a p53 mutant was shown to stimulate the multi drug resistance (MDR1) gene whereas WT p53 represses its expression)




Selective loss of specific p53 transcriptionaltargets• The p53 mutant (R213Q) is defective in its ability to up-regulate cell cycle arrest proteins and pro-apoptotic factors, but is highly effective at activating MDM2 (Such a mutant is likely to compromise the function of the WT protein)




Direct inhibition of signalling pathways throughaltered protein-protein interactions-The p53 mutant (R248W) binds and inhibits the MRN complex, preventing its recruitment toDNA double-stranded breaks. This inhibits ATMfunction, thereby providing a mechanism forincreased genomic instability.

What determines the nature and severity of the p53 dependent response?

1. Amplitude and duration of p53 activation




2. The different covalent modifications of p53 (p53 can be modified through ubiquitination, phosphorylation, acetylation and methylation)

The amplitude and duration of p53 activation dictates the final outcome of a p53 dependent response.




Explain this in a little more detail.

If p53 is induced for a long time at high levels, perhaps it is more likely to induce transcription from promoters which are less sensitive to p53 (e.g pro-apoptotic genes), vs promoters that are sensitive to p53 (e.g MDM2)

How does the phosphorylation status of p53 affect its activity?

Low levels of p53 phosphorylation are sufficient to displace MDM2, while higher levels promote the recruitment of transcriptional co-activators.




Because the affinity of p53 for the promoters of target genes varies (high: MDM2 &21 vs low apoptotic genes), higher levels of phosphorylation may be required to promote transcription of less sensitive genes